Evolus (EOLS) Net Income (QoQ) (2017 - 2026)
Evolus (EOLS) Net Income (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.93 Bn | 32.19 Bn | 1.97 Bn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.24 Bn | 18.43 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn |
| 10 | Evolus | 400.25 Mn | 350.45 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,310.77% |
| Dec 31, 2025 | 100.83% |
| Sep 30, 2025 | 8.20% |
| Jun 30, 2025 | 9.26% |
| Mar 31, 2025 | -178.19% |
| Dec 31, 2024 | 64.57% |
| Sep 30, 2024 | -68.90% |
| Jun 30, 2024 | 13.42% |
| Mar 31, 2024 | -10.80% |
| Dec 31, 2023 | 30.09% |
| Sep 30, 2023 | 6.71% |
| Jun 30, 2023 | -22.64% |
| Mar 31, 2023 | -12.36% |
| Dec 31, 2022 | 35.08% |
| Sep 30, 2022 | 13.61% |
| Jun 30, 2022 | -34.11% |
| Mar 31, 2022 | 3.72% |
| Dec 31, 2021 | 6.46% |
| Sep 30, 2021 | -24.56% |
| Jun 30, 2021 | -343.73% |